| pubmed-article:15113522 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15113522 | lifeskim:mentions | umls-concept:C0017319 | lld:lifeskim |
| pubmed-article:15113522 | lifeskim:mentions | umls-concept:C0004927 | lld:lifeskim |
| pubmed-article:15113522 | lifeskim:mentions | umls-concept:C0039943 | lld:lifeskim |
| pubmed-article:15113522 | lifeskim:mentions | umls-concept:C0150600 | lld:lifeskim |
| pubmed-article:15113522 | lifeskim:mentions | umls-concept:C0681939 | lld:lifeskim |
| pubmed-article:15113522 | lifeskim:mentions | umls-concept:C0278329 | lld:lifeskim |
| pubmed-article:15113522 | lifeskim:mentions | umls-concept:C1707450 | lld:lifeskim |
| pubmed-article:15113522 | pubmed:issue | 502 | lld:pubmed |
| pubmed-article:15113522 | pubmed:dateCreated | 2004-4-28 | lld:pubmed |
| pubmed-article:15113522 | pubmed:abstractText | In December 2000, the Committee for Safety of Medicines (CSM) advised that thioridazine may prolong QT intervals risking arrhythmias. We investigated the impact on general practitioner prescribing of thioridazine using a time series analysis. Numbers of items and costs of antipsychotics and benzodiazepines prescribed in Leeds from May 1999 until April 2002 were collated. Post-advice, thioridazine prescriptions dropped by 810 items per month (95% confidence interval = 420 to 1200, P < 0.001) but others increased slightly in response. Costs mimicked these changes. Fresh criteria are proposed for appraising the quality of evidence needed to inform future urgent facsimile transmissions. | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15113522 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15113522 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15113522 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15113522 | pubmed:month | May | lld:pubmed |
| pubmed-article:15113522 | pubmed:issn | 0960-1643 | lld:pubmed |
| pubmed-article:15113522 | pubmed:author | pubmed-author:AllgarVictori... | lld:pubmed |
| pubmed-article:15113522 | pubmed:author | pubmed-author:TompkinsCharl... | lld:pubmed |
| pubmed-article:15113522 | pubmed:author | pubmed-author:WrightNat M... | lld:pubmed |
| pubmed-article:15113522 | pubmed:author | pubmed-author:GreenwoodDarr... | lld:pubmed |
| pubmed-article:15113522 | pubmed:author | pubmed-author:RobertsAlison... | lld:pubmed |
| pubmed-article:15113522 | pubmed:author | pubmed-author:LaurenceGilli... | lld:pubmed |
| pubmed-article:15113522 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15113522 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:15113522 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15113522 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15113522 | pubmed:pagination | 370-3 | lld:pubmed |
| pubmed-article:15113522 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:meshHeading | pubmed-meshheading:15113522... | lld:pubmed |
| pubmed-article:15113522 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15113522 | pubmed:articleTitle | Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis. | lld:pubmed |
| pubmed-article:15113522 | pubmed:affiliation | Centre for Research in Primary Care, Leeds. n.wright@leeds.ac.uk | lld:pubmed |
| pubmed-article:15113522 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15113522 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15113522 | lld:pubmed |
